Agent Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Carisma Therapeuticscarismatx.comSeries B · May 2017 · $12M

CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).

BiotechPhiladelphia, US

Steven Kelly(Executive Officer, Director)in

BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)in

Board seatBruce Peacock· per SEC Form D

Co-investorsAju IB Investment Anzu Partners Grazia Equity GmbH HealthCap MRL Ventures Fund Solasta Ventures +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.